Effect of inhaled budesonide on surfactant protein expression in asthmatic mice

Allergy and Asthma Proceedings

Volumn 29, Issue 5, 2008, Pages 486-492

  Yu, Zhi Wei ^a   Zhang, Jian Hua ^b  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Asthma; Budesonide; Mice; Surfactant protein a; Surfactant protein B; TGF beta signaling; Therapeutic target; Transforming growth factor beta

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; OVALBUMIN; SMAD PROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; FEMALE; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; LUNG LAVAGE; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ADMINISTRATION, INHALATION; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHODILATOR AGENTS; BUDESONIDE; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 54049135241     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3155     Document Type: Article

References (25)

1. Ramin SM, Vidaeff AC, Gilstrap LC III, et al. The effects of dexamethasone and betamethasone on surfactant protein-B messenger RNA expression in human type II pneumocytes and human lung adenocarcinoma cells. Am J Obstet Gynecol 190: 952-959, 2004.
2. Brandt EB, Mingler MK, Stevenson MD, et al. Surfactant protein D alters allergic lung responses in mice and human subjects. J Allergy Clin Immunol 00:00-00, 2008. (Epub ahead of print March 18, 2008.)
3. Fried M. Advances in the understanding of allergic asthma. Allergy Asthma Proc 28:614-619, 2007.
4. Coutts A, Chen G, Stephens N, et al. Release of biologically active TGF-beta from airway smooth muscle cells induces autocrine synthesis of collagen. Am J Physiol Lung Cell Mol Physiol 280:L999-L1008, 2001.
5. Kato Y, Fujisawa T, Nishimori H, et al. Leukotriene D4 induces production of transforming growth factor-betal by eosinophils. Int Arch Allergy Immunol 137:17-20, 2005.
6. Bartram U, and Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 125:754-765, 2004.
7. Knight DA, Lane CL, and Stick SM. Does aberrant activation of the epithelial-mesenchymal trophic unit play a key role in asthma or is it an unimportant sideshow? Curr Opin Pharmacol 4:251-256, 2004.
8. Yamamoto T, Imoto S, Sekine Y, et al. Involvement of NF-kappaB in TGF-beta-mediated suppression of IL-4 signaling. Biochem Biophys Res Commun 313:627-634, 2004.
9. Kumar RK, Herbert C, and Kasper M. Reversibility of airway inflammation and remodelling following cessation of antigenic challenge in a model of chronic asthma. Clin Exp Allergy 34: 1796-1802, 2004.
10. Gong PH, Gao ZC, Hu P, et al. Investigation of the measurement of murine airway hyperresponsiveness and the therapeutic effects of budesonide on ovalbumin sensitized and challenged mice. Chin Med J (Engl) 118:1959-1964, 2005.
11. Leigh R, Ellis R, Wattie J, et al. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 27: 526-535, 2002.
12. Corsico A, Milanese M, Baraldo S, et al. Small airway morphology and lung function in the transition from normality to chronic airway obstruction. J Appl Physiol 95:441-447, 2003.
13. Brey EM, Lalani Z, Johnston C, et al. Automated selection of DAB-labeled tissue for immunohistochemical quantification. J Histochem Cytochem 51:575-584, 2003.
14. Richter A, Puddicombe SM, Lordan JL, et al. The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 25:385-391, 2001.
15. Duvernelle C, Freund V, and Frossard N. Transforming growth factor-beta and its role in asthma. Pulm Pharmacol Ther 16:181-196, 2003.
16. Derynck R, and Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584, 2003.
17. Gentile DA, Doyle WJ, Zeevi A, et al. Association between TNF-alpha and TGF-beta genotypes in infants and parental history of allergic rhinitis and asthma. Hum Immunol 65:347-351, 2004.
18. Tanaka H, Komai M, Nagao K, et al. Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice. Am J Respir Cell Mol Biol 31:62-68, 2004.
19. Rosendahl A, Checchin D, Fehniger TE, et al. Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation. Am J Respir Cell Mol Biol 25:60-68, 2001.
20. McMillan SJ, Xanthou G, and Lloyd CM. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: Effect on the Smad signaling pathway. J Immunol 174:5774-5780, 2005.
21. Ward C, and Walters H. Airway wall remodelling: The influence of corticosteroids. Curr Opin Allergy Clin Immunol 5:43-48, 2005.
22. Kurashima K, Ogawa H, Ohka T, et al. A pilot study of surfactant inhalation in the treatment of asthmatic attack. Arerugi 40:160-163, 1991.
23. van de Graaf EA, Jansen HM, Lutter R, et al. Surfactant protein A in bronchoalveolar lavage fluid. J Lab Clin Med 120:252-263, 1992.
24. Haczku A, Atochina EN, Tomer Y, et al. The late asthmatic response is linked with increased surface tension and reduced surfactant protein B in mice. Am J Physiol Lung Cell Mol Physiol 283:L755-L765, 2002.
25. Jarjour NN, and Enhorning G. Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant. Am J Respir Crit Care Med 160:336-341, 1999.